Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Inozyme Pharma Inc. logo

Inozyme Pharma Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

7.66
 
USD
  
0.27
  
(3.65%)
Optionable: No  Market Cap: 419 M  90-day average vol: 541,626

Previous close: 7.39  Open: 7.53  Bid: 7.28  Ask: 7.9
52 week range    
2.69   
   7.73
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 29th March 2024
58
MarketXLS Rank
60
Value
84
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

INZY Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-2.4-1.78-1.37
Basic EPS total-2.4-1.78-1.37
Basic weighted shares outstanding11 M24 M38 M52 M
Depreciation674000.0700000.0800000.0
Depreciation unreconciled-217000.0
DepreciationAndAmortization-217000.0674000.0700000.0800000.0
Diluted EPS total-5.11-2.4-1.78-1.37
Diluted normalized net income/share-5.11-1.78-1.37
Diluted weighted shares outstanding11 M38 M52 M
GeneralAndAdministrativeExpense11 M19 M21 M21 M
Income before tax-56 M-57 M-67 M-71 M
Interest income370000.0211000.02 M8 M
InterestExpenseNonOperating262000.03 M
MiscOtherSpecialCharges247000.0-189000.0-319000.0-28000.0
Net income from total operations-56 M-57 M-67 M-71 M
NetIncomeCommonStockholders-56 M-57 M-67 M-71 M
NetIncomeContinuousOperations-56 M-57 M-67 M-71 M
NetNonOperatingInterestIncomeExpense370000.0211000.02 M5 M
Normalized income-45 M-56 M
Operating income-57 M-57 M-69 M-76 M
Operating income before depreciation (EBITDA)-56 M-56 M-68 M-72 M
OperatingExpense57 M57 M69 M76 M
Other income net-247000.0189000.0319000.028000.0
OtherGandA11 M19 M21 M21 M
OtherOperatingExpenses700000.0700000.0900000.0
Research & development expense46 M38 M48 M55 M
ResearchExpense46 M38 M48 M55 M
SalariesAndWages400000.0
Selling Gen & administrative expense11 M19 M21 M21 M
Total Income available for interest expense (EBIT)-56 M-57 M-67 M-68 M
Total common shares outstanding23 M24 M44 M
Total net income-56 M-57 M-67 M-71 M
Total ordinary shares62 M62 M62 M62 M
TotalExpenses57 M57 M69 M76 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University